{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:28:26Z","timestamp":1790234906024,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["AI18958"],"award-info":[{"award-number":["AI18958"]}]},{"name":"National Institute of Health","award":["DK101323"],"award-info":[{"award-number":["DK101323"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.064","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T06:18:06Z","timestamp":1490336286000},"page":"2511-2519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Sublingual targeting of STING with 3\u20323\u2032-cGAMP promotes systemic and mucosal immunity against anthrax toxins"],"prefix":"10.1016","volume":"35","author":[{"given":"Tara L.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbae","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley E.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Cormet-Boyaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper N.","family":"Boyaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.064_b0005","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0010","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.02.064_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2010.12.014","article-title":"Sublingual mucosa: a new vaccination route for systemic and mucosal immunity","volume":"54","author":"Kweon","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0025","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.4049\/jimmunol.0803740","article-title":"Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection","volume":"183","author":"Cuburu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0030","doi-asserted-by":"crossref","first-page":"e1001397","DOI":"10.1371\/journal.pbio.1001397","article-title":"Inside the mucosal immune system","volume":"10","author":"McGhee","year":"2012","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0035","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2010.04.013","article-title":"Persistence of mucosal and systemic immune responses following sublingual immunization","volume":"28","author":"Negri","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0040","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/IAI.00536-10","article-title":"Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach","volume":"78","author":"Raghavan","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.02.064_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0264-410X(99)00168-1","article-title":"The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)","volume":"18","author":"Cheng","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0050","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.0902795","article-title":"Contributions of edema factor and protective antigen to the induction of protective immunity by Bacillus anthracis edema toxin as an intranasal adjuvant","volume":"185","author":"Duverger","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0055","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0060","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0264-410X(02)00532-7","article-title":"Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression","volume":"21","author":"Gagliardi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.064_b0070","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/2051013613501988","article-title":"Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants","volume":"1","author":"Dubensky","year":"2013","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.vaccine.2017.02.064_b0080","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.4049\/jimmunol.1302718","article-title":"The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection","volume":"193","author":"Zhang","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0085","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/eji.201344127","article-title":"Recognition of cytosolic DNA by cGAS and other STING-dependent sensors","volume":"44","author":"Bhat","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.02.064_b0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of Type I Interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.02.064_b0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.02.064_b0105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.02.064_b0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1301812","article-title":"MPYS\/STING-mediated TNF-alpha, not type I IFN, is essential for the mucosal adjuvant activity of (3\u2032-5\u2032)-cyclic-di-guanosine-monophosphate in vivo","volume":"192","author":"Blaauboer","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.02.064_b0120","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.02.064_b0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20092695","article-title":"Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response","volume":"207","author":"Swanson","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2017.02.064_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12284","article-title":"Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT)","volume":"27","author":"DeBoer","year":"2016","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0135","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0140","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/mi.2014.105","article-title":"Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization","volume":"8","author":"Jee","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0145","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4049\/jimmunol.170.1.454","article-title":"Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/mi.2013.43","article-title":"IKKbeta in intestinal epithelial cells regulates allergen-specific IgA and allergic inflammation at distant mucosal sites","volume":"7","author":"Bonnegarde-Bernard","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0160","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"Cuburu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0165","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3\u2032,5\u2032)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0170","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/CVI.00119-07","article-title":"The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant","volume":"14","author":"Ebensen","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0175","doi-asserted-by":"crossref","first-page":"e104824","DOI":"10.1371\/journal.pone.0104824","article-title":"Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge","volume":"9","author":"Sanchez","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.064_b0180","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1093\/nar\/gku569","article-title":"Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS and STING","volume":"42","author":"Wu","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2017.02.064_b0185","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.4049\/jimmunol.1402705","article-title":"DNA-mediated cyclic GMP-AMP synthase-dependent and -independent regulation of innate immune responses","volume":"194","author":"Motani","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06670","article-title":"The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo","volume":"4","author":"Blaauboer","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2017.02.064_b0195","doi-asserted-by":"crossref","first-page":"e110150","DOI":"10.1371\/journal.pone.0110150","article-title":"Cyclic GMP-AMP displays mucosal adjuvant activity in mice","volume":"9","author":"Skrnjug","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.064_b0200","doi-asserted-by":"crossref","first-page":"e77846","DOI":"10.1371\/journal.pone.0077846","article-title":"Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides","volume":"8","author":"Yi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.064_b0205","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/embor.2013.132","article-title":"Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome","volume":"14","author":"Abdul-Sater","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1016\/j.vaccine.2017.02.064_b0210","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.4049\/jimmunol.1003789","article-title":"Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production","volume":"186","author":"Brereton","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0215","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/mi.2014.111","article-title":"Cholera toxin adjuvant promotes a balanced Th1\/Th2\/Th17 response independently of IL-12 and IL-17 by acting on Gsalpha in CD11b(+) DCs","volume":"8","author":"Mattsson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0220","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/v3060906","article-title":"RIG-I like receptors in antiviral immunity and therapeutic applications","volume":"3","author":"Ireton","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.02.064_b0225","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.4049\/jimmunol.0803568","article-title":"CCR7-CCL19\/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination","volume":"182","author":"Song","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0230","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/mi.2013.16","article-title":"The immune complex CTA1-DD\/IgG adjuvant specifically targets connective tissue mast cells through FcgammaRIIIA and augments anti-HPV immunity after nasal immunization","volume":"6","author":"Fang","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.02.064_b0235","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1016\/j.vaccine.2009.03.069","article-title":"The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen","volume":"27","author":"McGowen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.064_b0240","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/2326-6066.CIR-13-0123","article-title":"STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer","volume":"2","author":"Chandra","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.vaccine.2017.02.064_b0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4306","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","volume":"7","author":"Fu","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.02.064_b0250","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T04:19:43Z","timestamp":1568953183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730289X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":50,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X1730289X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual targeting of STING with 3\u20323\u2032-cGAMP promotes systemic and mucosal immunity against anthrax toxins","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}